An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer is a research paper published in Molecular Oncology (2020). On theSindex it has a DataRank of 0.425. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: CA226342‐01
NCI NIH HHS
Grant: K99 CA226342
Pancreatic Cancer Action Network
Grant: 17‐70‐25‐ESCO
Pancreatic Cancer Action Network
Grant: 18-65-SHRO
Pancreatic Cancer Action Network
Grant: 18‐65‐SHRO
NCI NIH HHS
Grant: R00 CA226342
NCI NIH HHS
Grant: CA226342-01
NCI NIH HHS
Grant: P30 CA008748
NIH HHS
Grant: S10 OD025279
NCI NIH HHS
Grant: K99-R00
National Cancer Institute
Grant: K99‐R00
Pancreatic Cancer Action Network
Grant: 17-70-25-ESCO
Hirshberg Foundation for Pancreatic Cancer Research
National Pancreas Foundation
National Institutes of Health
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals